VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 188 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $246 | -34.6% | 57 | 0.0% | 0.00% | – |
| Q2 2023 | $376 | -2.8% | 57 | 0.0% | 0.00% | – |
| Q1 2023 | $387 | -8.1% | 57 | 0.0% | 0.00% | – |
| Q4 2022 | $421 | -57.9% | 57 | -32.9% | 0.00% | – |
| Q3 2022 | $1,000 | -99.9% | 85 | -99.9% | 0.00% | -100.0% |
| Q2 2022 | $804,000 | +21.8% | 73,767 | +26.4% | 0.00% | +33.3% |
| Q1 2022 | $660,000 | -4.5% | 58,367 | +32.6% | 0.00% | 0.0% |
| Q4 2021 | $691,000 | -13.8% | 44,010 | -5.9% | 0.00% | -25.0% |
| Q3 2021 | $802,000 | -12.9% | 46,766 | +9.2% | 0.00% | 0.0% |
| Q2 2021 | $921,000 | +63.9% | 42,817 | +14.4% | 0.00% | +33.3% |
| Q1 2021 | $562,000 | +49.1% | 37,425 | +30.4% | 0.00% | +50.0% |
| Q4 2020 | $377,000 | +62.5% | 28,703 | +19.3% | 0.00% | +100.0% |
| Q3 2020 | $232,000 | +64.5% | 24,059 | +95.5% | 0.00% | 0.0% |
| Q2 2020 | $141,000 | – | 12,307 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |